Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Leusm
Catherine Smith, MD
SmithLabSF
Lots of FLT3i action in the first #AML session of the day! Some takeaways. THREAD #ASH20 #leusm 1)Git + chemo: Of pts achieving FLT3 mutational clearance, only ~30% achieve this
Read more
Catherine Smith, MD
SmithLabSF
Ok, one last thread with #FinalFLT3 thoughts on today’s #AML talks. #ASH20 #ASHFromHome #ASHtogether #leusm 1) First, Dr. Andrew Wei with an excellent presentation on AML M16 (sor vs placebo
Read more
Catherine Smith, MD
SmithLabSF
Be still my heart, you know I love me some drug resistance talks! Session 604 was! Some highlights. THREAD. #ASH20 #ASHFromHome #ASHtogether #leusm #ImaHemeDork. 1)First up, on target resistance wins
Read more
Faheema Hasan
faheema_hasan
mini #tweetorial on Ph like ALL/“Ph-like”or BCR-ABL1-like ALL was described by the COG& Dutch COG by GEP in 2009Adopted in 2016 update of WHO as provisional entitylacks the BCR-ABL1 translocation
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree